Patents by Inventor Christiane Marie-Paule Simone Jeanne FERON

Christiane Marie-Paule Simone Jeanne FERON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • P AERUGINOSA PCRV-LINKED ANTIGEN VACCINES
    Publication number: 20240139304
    Abstract: The present invention discloses a conjugate comprising an antigen (for example a saccharide antigen) covalently linked to a Pseudomonas aeruginosa PcrV carrier protein comprising an amino acid sequence which is at least 80% identical to the sequence of SEQ ID NO:1-4, wherein the antigen is linked (either directly or through a linker) to an amino acid residue of the P. aeruginosa PcrV carrier protein. The invention also discloses Pseudomonas aeruginosa PcrV proteins that contain glycosylation site consensus sequences.
    Type: Application
    Filed: August 31, 2022
    Publication date: May 2, 2024
    Inventors: Christiane Marie-Paule Simone Jeanne FERON, Stefan Jochen KEMMLER, Michael Thomas KOWARIK, Julien Laurent QUEBATTE
  • PcrV-linked antigen vaccines
    Patent number: 11406696
    Abstract: The present invention discloses a conjugate comprising an antigen (for example a saccharide antigen) covalently linked to a Pseudomonas aeruginosa PcrV carrier protein comprising an amino acid sequence which is at least 80% identical to the sequence of SEQ ID NO:1-4, wherein the antigen is linked (either directly or through a linker) to an amino acid residue of the P. aeruginosa PcrV carrier protein. The invention also discloses Pseudomonas aeruginosa PcrV proteins that contain glycosylation site consensus sequences.
    Type: Grant
    Filed: October 19, 2016
    Date of Patent: August 9, 2022
    Inventors: Christiane Marie-Paule Simone Jeanne Feron, Stefan Jochen Kemmler, Michael Thomas Kowarik, Julien Laurent Quebatte
  • IMMUNOGENIC COMPOSITION
    Publication number: 20210252081
    Abstract: The present invention discloses an engineered bacteriophage capable of binding to a commensal bacterium and inserting its genome polynucleotide into the commensal bacterium, but incapable of producing progeny, incapable of carrying out a lysogenic cycle and incapable of carrying out a lytic cycle within the commensal bacterium, wherein the engineered bacteriophage comprises a genome polynucleotide including at least one gene encoding at least one heterologous antigen(s) under the control of a promoter.
    Type: Application
    Filed: June 18, 2019
    Publication date: August 19, 2021
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Christiane Marie-Paule Simone Jeanne FERON, Sandra GIANNINI
  • P AERUGINOSA PCRV-LINKED ANTIGEN VACCINES
    Publication number: 20190091319
    Abstract: The present invention discloses a conjugate comprising an antigen (for example a saccharide antigen) covalently linked to a Pseudomonas aeruginosa PcrV carrier protein comprising an amino acid sequence which is at least 80% identical to the sequence of SEQ ID NO:1-4, wherein the antigen is linked (either directly or through a linker) to an amino acid residue of the P. aeruginosa PcrV carrier protein. The invention also discloses Pseudomonas aeruginosa PcrV proteins that contain glycosylation site consensus sequences.
    Type: Application
    Filed: October 19, 2016
    Publication date: March 28, 2019
    Applicant: GLAXOSMITHKLINE BIOLOGICALS, S.A.
    Inventors: Christiane Marie-Paule Simone Jeanne FERON, Stefan Jochen KEMMLER, Michael Thomas KOWARIK, Julien Laurent QUEBATTE
  • MODIFIED HOST CELLS AND USES THEREOF
    Publication number: 20170035900
    Abstract: Described herein are modified host cells useful in the production of bioconjugates that can be used to vaccinate subjects against infection with Pseudomonas. The genomes of the modified host cells described herein comprise genes that encode proteins involved in glyosylation of proteins as well as genes specific to the production of Pseudomonas-specific antigens.
    Type: Application
    Filed: October 13, 2014
    Publication date: February 9, 2017
    Inventors: Michael KOWARIK, Stefan J. KEMMLER, Julien L. QUEBATTE, Christiane Marie-Paule Simone Jeanne FERON